- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Longevity Health Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Mo | Longevity Health Holdings, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 26.03. | Longevity Health Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.03. | Carmell Corp. Rebrands, Announces Growth Initiatives And Management Changes | - | RTTNews | ||
| 05.03. | Longevity Health Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 24.01. | Carmell Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture to Carmell Corporation | 162 | GlobeNewswire (Europe) | NEWPORT BEACH, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (formerly Elevai Labs Inc.) (the "Company" or "PMGC") (Nasdaq: ELAB) a diversified holding company today announced the closing... ► Artikel lesen | |
| LONGEVITY HEALTH Aktie jetzt für 0€ handeln | |||||
| 16.01. | Carmell Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 03.01. | Carmell Corporation Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out | 230 | GlobeNewswire (Europe) | PITTSBURGH, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced... ► Artikel lesen | |
| 02.01. | Why Biotechnology Company Carmell Shares Are Rocketing On Thursday | 16 | Benzinga.com | ||
| 02.01. | Carmell's earning potential swells with Elevai acquisition | 3 | Seeking Alpha | ||
| 02.01. | Carmell Corporation acquires Elevai assets for $1.1M | 3 | Investing.com | ||
| 02.01. | Carmell Corporation übernimmt Elevai-Vermögenswerte für 1,1 Mio. US-Dollar | 2 | Investing.com Deutsch | ||
| 02.01. | Carmell Corporation Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a wholly owned subsidiary of PMGC Holdings Inc. | 519 | GlobeNewswire (Europe) | PITTSBURGH, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced... ► Artikel lesen | |
| 31.12.24 | Carmell Corp - 8-K, Current Report | - | SEC Filings | ||
| 24.12.24 | Why Biotechnology Company Carmell Shares Are Seeing Blue Skies Tuesday? | 3 | Benzinga.com | ||
| 24.12.24 | Carmell announces PIPE investment, shares up more than 20% | 1 | Seeking Alpha | ||
| 24.12.24 | Carmell Corporation Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out | 47 | GlobeNewswire (Europe) | PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced... ► Artikel lesen | |
| 20.11.24 | Carmell Corp - 8-K, Current Report | - | SEC Filings | ||
| 19.11.24 | Carmell Corp - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings |
Seite:
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PALATIN TECHNOLOGIES | 0,489 | +2,41 % | Palatin: Bremelanotide-Tirzepatide Combination Achieves Primary Endpoint In Phase 2 Obesity Study | WASHINGTON (dpa-AFX) - Palatin Technologies Inc. (PTN) announced that its BMT-801 Phase 2 obesity co-administration study met its primary endpoint and was highly statistically significant. The... ► Artikel lesen | |
| BIOXXMED | 0,800 | +14,29 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 31.03.2025 | The following instruments on Xetra do have their last trading day on 31.03.2025.Die folgenden Instrumente auf Xetra haben ihren letzten Handelstag am 31.03.2025.ISIN NameDE000A4BGGE4 bioXXmed AG ► Artikel lesen | |
| ORGANOVO | 2,040 | -4,67 % | Organovo, Inc.: Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements | SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches... ► Artikel lesen | |
| OCUGEN | 0,625 | +7,67 % | Ocugen, Inc. - 8-K, Current Report | ||
| SIRONA BIOCHEM | 0,037 | -100,00 % | XFRA ZSB: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSIRONA BIOCHEM CORP.... ► Artikel lesen | |
| BIO-GATE | 0,760 | 0,00 % | Bio-Gate: Vielversprechende Wachstumschancen | Nach Darstellung der Analysten Matthias Greiffenberger und Cosmin Filker von GBC hat die Bio-Gate AG im Geschäftsjahr 2024 (per 31.12.) einen leichten Umsatzrückgang verbucht, besitzt aufgrund der innovativen... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,672 | 0,00 % | Bayers Krebsmedikamente, Defence Therapeutics' Krebs-Impfung, Novo Nordisks Fettkiller - mit Spezialisierung zurück in die Erfolgsspur | Die neuen Handelszölle drohen die globalen Lieferketten der Pharmaindustrie zu destabilisieren, die Generikapreise zu erhöhen und Innovationszyklen zu verlangsamen. Als Sieger kann aus diesem Umfeld... ► Artikel lesen | |
| VAXART | 0,342 | -1,04 % | Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SOUTH SAN FRANCISCO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced that on March 24, 2025, the independent members of the Board... ► Artikel lesen | |
| CELLECTAR BIOSCIENCES | 0,254 | -5,22 % | Cellectar Biosciences: Multibagger mit Ansage? | Cellectar Biosciences (WKN: A3DQSD) heißt unsere Top-Spekulation der Stunde. Das auf Radiopharmaka gegen Krebs spezialisierte Biotechunternehmen konnte gestern eine wichtige Einigung mit der US-Gesundheitsbehörde... ► Artikel lesen | |
| BURCON NUTRASCIENCE | 0,049 | -17,11 % | Burcon NutraScience Corporation: Burcon Integrates Protein Technologies at Galesburg Facility | Vancouver, British Columbia--(Newsfile Corp. - April 1, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of... ► Artikel lesen | |
| AFFIMED | 0,930 | -100,00 % | Affimed N.V.: Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting | MANNHEIM, Germany, March 25, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer,... ► Artikel lesen | |
| IMMUNIC | 0,945 | -0,42 % | EQS-News: Immunic AG: Immunic, Inc. to Participate in Scientific and Industry Conferences in April | Issuer: Immunic AG
/ Key word(s): Conference
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
01.04.2025 / 12:30 CET/CEST
The issuer is solely... ► Artikel lesen | |
| AIM IMMUNOTECH | 0,103 | 0,00 % | AIM ImmunoTech Inc.: AIM ImmunoTech Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update | Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer space Expected milestones over... ► Artikel lesen | |
| T2 BIOSYSTEMS | 0,130 | +71,05 % | T2 Biosystems, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | ||
| CEL-SCI | 0,197 | +7,91 % | CEL-SCI Aktie: Risiken mehren sich | CEL-SCI hat am 18. März 2025 den Abschluss eines Finanzierungsangebots in Höhe von 2,5 Millionen Dollar bekannt gegeben. Dabei wurden 16 Millionen Stammaktien oder vorfinanzierte Optionsscheine ausgegeben.... ► Artikel lesen |
LONGEVITY HEALTH HOLDINGS INC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,131 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LONGEVITY HEALTH HOLDINGS INC finden Sie auf Wallstreet Online.
